The short version. Rapid-dissolve tablets, sublingual drops, troches and lozenges exist because a lot of people will not inject themselves, and that is a real reason to choose one. Two things the marketing rarely says. The large randomised trials people have in mind when they picture these drugs were run on the FDA-approved injectables, not on compounded oral versions, which have no equivalent trial base at all. And the price is usually unpublished: three of the five providers here put no figure on an oral course until you are inside an intake, and one of the two that does publish shows two different numbers on the same page. Needle-free is a genuine benefit. It is not a free one, and it is not a measured one.
01 / 06What the format actually changes
An injection puts the drug under the skin, where absorption is well characterised and the dose that arrives is close to the dose given. Anything taken by mouth has to survive a longer journey, and the sublingual and rapid-dissolve formats exist to shorten it by absorbing through the tissue under the tongue rather than through the gut.
That is the pitch, and it is plausible chemistry. The question a buyer cannot answer from a product page is how much of the dose actually arrives by that route for these particular molecules at these particular strengths, because that is a measurement, and for compounded preparations it is a measurement that has largely not been published.
02 / 06What an oral course actually costs
The first difficulty is that most of this market will not tell you. Of the five providers here, three publish no figure for an oral course anywhere we could reach without starting an intake.
| Provider | Oral format | Published price | What it includes |
|---|---|---|---|
 Henry Meds | dissolving tablets, sublingual drops | $179 / mo | provider visits, medication, supplies, ongoing support |
 Ready Med | sublingual tablets or drops | $249 / mo | headline price; the same page also states a $297 monthly membership with medication included |
 Shed | sublingual drops, dissolvable lozenges | not published | injections also offered |
| PlexusDx | tablet, troche, capsule, lozenge, sublingual | not published | six compounds |
 Strut Health | oral, dose-tiered | not published for GLP-1 | publishes oral hormone prices by dose |
Read from each provider’s own live pages on 22 September 2026. Where a provider does not publish a figure on the pages we could reach, we say so rather than substituting an estimate.
The two that do publish disagree with themselves or with each other. Henry Meds is the clearest: $179 a month for oral semaglutide, as mint-flavoured dissolving tablets or sublingual drops, with provider visits, medication, supplies and ongoing support stated as included. Ready Med leads with “Only $249 per Month” and, further down the same page, describes a $297 monthly membership in which the cost of medication is included. Both numbers are theirs and both are on one page, which is exactly the situation a buyer cannot resolve from the outside.
The other three publish nothing at all. That is not evidence of a bad price. It is evidence that in this format the price is a conversation rather than a number, and that you cannot comparison-shop it the way you can a branded injectable.
03 / 06The evidence gap nobody prices in
When people picture what these drugs do, they are picturing results from the large randomised programmes run on the branded injectables. Those trials were run on the FDA-approved products, by their manufacturers, in the injectable form.
There is no equivalent trial base for compounded oral semaglutide or tirzepatide. No STEP or SURMOUNT-equivalent randomised trial of a compounded oral version has been published. That does not mean the oral form does nothing. It means the number you have in your head came from a different product in a different form, and it was never measured for this one.
The most honest statement we found on any provider page says exactly this, and it is worth quoting in full because it is unusually direct: “Data from clinical trials on FDA-approved medications should not be used to make assessments related to compounded medications.” That is Henry Meds, on its own oral semaglutide page, telling you not to do the thing its own category’s marketing depends on you doing.
04 / 06Who sells which format
| Provider | Formats offered | Breadth |
|---|---|---|
| Ready Med | sublingual tablets and drops | GLP-1 oral, two formats |
| Shed | weekly injections, daily sublingual drops, dissolvable lozenges | GLP-1 only, three formats |
| PlexusDx | injection, oral tablet, troche, capsule, lozenge, sublingual | six compounds |
| Henry Meds | dissolving tablets and sublingual drops | GLP-1 oral, two formats |
| Strut Health | oral, dose-tiered | men’s hormones |
PlexusDx is the widest of the five on format, listing injection, tablet, troche, capsule, lozenge and sublingual across six compounds, though it publishes no price for any of them. Shed is the only one here offering the same molecule as an injection, a sublingual drop and a lozenge, which is the closest thing in this set to a genuine format choice within one provider. ⭐ Nobody on this page runs the oral form across more than two therapeutic areas. The companies that treat rapid-dissolve as a house specialism rather than an option within weight loss are not represented here, which is a real gap in this comparison and one we would rather state than paper over.
05 / 06Who tells you the trade
The trade is real and it is not hidden information. The question is who states it before you pay rather than after.
| Provider | States compounded is not FDA reviewed | Warns against transferring trial data | Publishes an oral price |
|---|---|---|---|
| Henry Meds | yes, on the product page | yes, explicitly | yes, $179 |
| Ready Med | not found on the page read | no | yes, $249 and $297 |
| Shed | not found on the page read | no | no |
| PlexusDx | not found on the page read | no | no |
| Strut Health | none found | no | by dose, for oral hormones |
Henry Meds is the clearest provider on this page and it is not close. Its oral semaglutide page states that compounded medications do not undergo pre-market review or an FDA-approval process, that they may differ in efficacy, safety, risk and side-effect profile from approved drugs, and that trial data from approved medicines should not be used to assess them. That last clause is the one that matters most for an oral format, and it is the one almost nobody else writes down.
Nobody else here comes close. Ready Med publishes two prices and no compounding disclosure we could find; Shed and PlexusDx publish neither. ★ For any company whose distinctive product IS the oral format, the evidence-transfer sentence is the most valuable thing it could add to its own page, because it is the one question a buyer of an oral compounded medicine should be asking and almost nobody in this category answers it.
06 / 06What this means for your decision
If you will not inject, the oral formats are a real option and the reason to pick one is that you will actually take it. A medication you avoid is worth nothing at any price.
Go in knowing two things. You will usually pay more for the oral version than for the injection of the same molecule, sometimes far more. And the evidence you are carrying in your head almost certainly came from the injectable, so it belongs to a different product than the one in the basket. Ask the provider what their oral price is against their own injection price, and ask what evidence exists for the oral form specifically. The answer to the second one is short, and a provider willing to say so is the one to trust on the first.
- Ready Med. Oral semaglutide tablets and drops. The $249 headline and the $297 membership, read in-browser 22 September 2026.
- Henry Meds. Oral semaglutide. Price, formats and the compounded-medication disclosure quoted above, read 22 September 2026.
- Shed. tryshed.com. Injection, sublingual drop and lozenge formats, read 22 September 2026.
- PlexusDx. plexusdx.com. Multi-format compounded offering, read 22 September 2026.
- Strut Health. struthealth.com. Oral dose-tiered pricing, read 22 September 2026.
- U.S. Food and Drug Administration. FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize. Regulatory context for compounded GLP-1.
Is sublingual semaglutide cheaper than the injection?
Not reliably, and on this page it is hard to check, because three of the five providers publish no oral price at all and none of the five publishes an injection price beside its oral one. Where a provider does sell both, ask for the two figures together before assuming the tablet is the economical choice.
Does oral or sublingual GLP-1 work as well as the injection?
There is no published randomised trial of compounded oral semaglutide or tirzepatide equivalent to the STEP and SURMOUNT programmes run on the approved injectables, so the honest answer is that it has not been measured the same way. That is a gap in evidence rather than evidence of failure, and it is a question for a prescriber.
What is the cheapest published oral option?
Of the prices we could read, Henry Meds at $179 a month for oral semaglutide, as dissolving tablets or sublingual drops, including provider visits and supplies. Ready Med publishes $249, and also describes a $297 membership with medication included, on the same page.
Why choose an oral format at all?
Because a lot of people will not self-inject, and a medication that is never taken does nothing. Adherence is a real clinical variable, and for some people the oral form is the only version they will actually use.
What should I ask before paying?
What the same provider charges for the injectable form of the same molecule, whether the price includes consultations and supplies, and what evidence exists for the oral version specifically rather than for the approved injectable.